Jupiter Life Line Hospitals Share Price
Sector:
1459.90 +19.85 (1.38%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1450.45
Today’s High
1476.40
52 Week Low
1177.05
52 Week High
1759.00
1456.30 +16.80 (1.17%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1438.80
Today’s High
1480.00
52 Week Low
1206.85
52 Week High
1770.00
Key Metrics
- Market Cap (In Cr) 9590.45
- Beta -
- Div. Yield (%) 0.07
- P/B 6.96
- TTM P/E 54.1
- Peg Ratio 0.87
- Sector P/E 22.44
- D/E 0
- Open Price 1453.6
- Prev Close 1440.05
Jupiter Life Line Hospitals Analysis
Price Analysis
-
1 Week-5.03%
-
3 Months-6.33%
-
6 Month-6.89%
-
YTD-7.89%
-
1 Year15.74%
Risk Meter
- 28% Low risk
- 28% Moderate risk
- 28% Balanced Risk
- 28% High risk
- 28% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 3
- 3
- 3
- 3
- Buy
- 2
- 2
- 2
- 1
- Hold
- 0.00
- 0.00
- 0.00
- 1
- Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 5
- 5
- 5
- 5
Jupiter Life Line Hospitals News
Hospital stocks rise as govt plans daycare cancer centers in district hospitals
2 min read . 01 Feb 2025Breakout stocks to buy or sell: Sumeet Bagadia recommends 5 shares to buy today
2 min read . 01 Feb 2025Three recently debt-free stocks mutual funds can’t get enough of
5 min read . 25 Nov 2024Jupiter Life Line Hospitals Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 1261.55
- Selling/ General/ Admin Expenses Total
- 526.62
- Depreciation/ Amortization
- 56.98
- Other Operating Expenses Total
- 207.77
- Total Operating Expense
- 1021.54
- Operating Income
- 240.01
- Net Income Before Taxes
- 257.7
- Net Income
- 193.5
- Diluted Normalized EPS
- 29.51
- Period
- 2025
- Total Assets
- 1904.89
- Total Liabilities
- 548.65
- Total Equity
- 1356.24
- Tangible Book Valueper Share Common Eq
- 206.16
- Period
- 2025
- Cashfrom Operating Activities
- 253.3
- Cashfrom Investing Activities
- -208.62
- Cashfrom Financing Activities
- 300.63
- Net Changein Cash
- 345.31
- Period
- 2024
- Total Revenue
- 1069.5
- Selling/ General/ Admin Expenses Total
- 461.29
- Depreciation/ Amortization
- 42.38
- Other Operating Expenses Total
- 180.17
- Total Operating Expense
- 873.31
- Operating Income
- 196.19
- Net Income Before Taxes
- 195.42
- Net Income
- 176.61
- Diluted Normalized EPS
- 28.68
- Period
- 2024
- Total Assets
- 1281.33
- Total Liabilities
- 112.3
- Total Equity
- 1169.04
- Tangible Book Valueper Share Common Eq
- 177.97
- Period
- 2024
- Cashfrom Operating Activities
- 114.52
- Cashfrom Investing Activities
- -246.14
- Cashfrom Financing Activities
- 128.16
- Net Changein Cash
- -3.47
- Period
- 2023
- Total Revenue
- 892.54
- Selling/ General/ Admin Expenses Total
- 373.51
- Depreciation/ Amortization
- 38.56
- Other Operating Expenses Total
- 160.53
- Total Operating Expense
- 731.98
- Operating Income
- 160.56
- Net Income Before Taxes
- 128.71
- Net Income
- 72.9
- Diluted Normalized EPS
- 11.31
- Period
- 2023
- Total Assets
- 985.53
- Total Liabilities
- 619.85
- Total Equity
- 365.69
- Tangible Book Valueper Share Common Eq
- 55.66
- Period
- 2023
- Cashfrom Operating Activities
- 176.4
- Cashfrom Investing Activities
- -94.25
- Cashfrom Financing Activities
- -51.06
- Net Changein Cash
- 31.1
- Period
- 2022
- Total Revenue
- 733.12
- Selling/ General/ Admin Expenses Total
- 306.86
- Depreciation/ Amortization
- 36.16
- Other Operating Expenses Total
- 130.11
- Total Operating Expense
- 615.56
- Operating Income
- 117.57
- Net Income Before Taxes
- 77.12
- Net Income
- 51.13
- Diluted Normalized EPS
- 7.79
- Period
- 2022
- Total Assets
- 908.7
- Total Liabilities
- 615.14
- Total Equity
- 293.55
- Tangible Book Valueper Share Common Eq
- 44.65
- Period
- 2022
- Cashfrom Operating Activities
- 136.97
- Cashfrom Investing Activities
- -85.25
- Cashfrom Financing Activities
- 32.2
- Net Changein Cash
- 83.93
- Period
- 2021
- Total Revenue
- 486.16
- Selling/ General/ Admin Expenses Total
- 220.17
- Depreciation/ Amortization
- 30.74
- Other Operating Expenses Total
- 100.15
- Total Operating Expense
- 449.51
- Operating Income
- 36.66
- Net Income Before Taxes
- 1.56
- Net Income
- -2.3
- Diluted Normalized EPS
- -0.35
- Period
- 2021
- Total Assets
- 788.91
- Total Liabilities
- 549.93
- Total Equity
- 238.98
- Tangible Book Valueper Share Common Eq
- 36.36
- Period
- 2021
- Cashfrom Operating Activities
- 123.41
- Cashfrom Investing Activities
- -295.85
- Cashfrom Financing Activities
- 184.29
- Net Changein Cash
- 11.85
- Period
- 2020
- Total Revenue
- 462.95
- Selling/ General/ Admin Expenses Total
- 198.27
- Depreciation/ Amortization
- 25.91
- Other Operating Expenses Total
- 102.02
- Total Operating Expense
- 406.06
- Operating Income
- 56.89
- Net Income Before Taxes
- 32.89
- Net Income
- 29.63
- Diluted Normalized EPS
- 4.52
- Period
- 2020
- Total Assets
- 602.92
- Total Liabilities
- 366.18
- Total Equity
- 236.74
- Tangible Book Valueper Share Common Eq
- 36.04
- Period
- 2020
- Cashfrom Operating Activities
- 74.21
- Cashfrom Investing Activities
- -43.39
- Cashfrom Financing Activities
- -31.74
- Net Changein Cash
- -0.92
- Period
- 2025-03-31
- Total Revenue
- 331.2
- Selling/ General/ Admin Expenses Total
- 135.02
- Depreciation/ Amortization
- 17.62
- Other Operating Expenses Total
- 52.32
- Total Operating Expense
- 266.1
- Operating Income
- 65.1
- Net Income Before Taxes
- 62.1
- Net Income
- 44.87
- Diluted Normalized EPS
- 6.84
- Period
- 2025-03-31
- Total Assets
- 1904.89
- Total Liabilities
- 548.65
- Total Equity
- 1356.24
- Tangible Book Valueper Share Common Eq
- 206.16
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 253.3
- Cashfrom Investing Activities
- -208.62
- Cashfrom Financing Activities
- 300.63
- Net Changein Cash
- 345.31
- Period
- 2024-12-31
- Total Revenue
- 320.64
- Selling/ General/ Admin Expenses Total
- 134.43
- Depreciation/ Amortization
- 13.97
- Other Operating Expenses Total
- 52.4
- Total Operating Expense
- 259.6
- Operating Income
- 61.04
- Net Income Before Taxes
- 66.55
- Net Income
- 52.51
- Diluted Normalized EPS
- 8.01
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 322.58
- Selling/ General/ Admin Expenses Total
- 133.68
- Depreciation/ Amortization
- 14.4
- Other Operating Expenses Total
- 53.91
- Total Operating Expense
- 261.99
- Operating Income
- 60.59
- Net Income Before Taxes
- 68.91
- Net Income
- 51.51
- Diluted Normalized EPS
- 7.86
- Period
- 2024-09-30
- Total Assets
- 1394.49
- Total Liabilities
- 136.08
- Total Equity
- 1258.41
- Tangible Book Valueper Share Common Eq
- 191.48
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 118.23
- Cashfrom Investing Activities
- -165.34
- Cashfrom Financing Activities
- -8.31
- Net Changein Cash
- -55.43
- Period
- 2024-06-30
- Total Revenue
- 287.13
- Selling/ General/ Admin Expenses Total
- 123.49
- Depreciation/ Amortization
- 11
- Other Operating Expenses Total
- 49.57
- Total Operating Expense
- 234.27
- Operating Income
- 52.85
- Net Income Before Taxes
- 60.14
- Net Income
- 44.61
- Diluted Normalized EPS
- 6.8
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 290.49
- Selling/ General/ Admin Expenses Total
- 123.18
- Depreciation/ Amortization
- 10.39
- Other Operating Expenses Total
- 52.25
- Total Operating Expense
- 236.32
- Operating Income
- 54.17
- Net Income Before Taxes
- 62.2
- Net Income
- 45.27
- Diluted Normalized EPS
- 6.37
- Period
- 2024-03-31
- Total Assets
- 1281.33
- Total Liabilities
- 112.3
- Total Equity
- 1169.04
- Tangible Book Valueper Share Common Eq
- 177.97
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 114.52
- Cashfrom Investing Activities
- -246.14
- Cashfrom Financing Activities
- 128.16
- Net Changein Cash
- -3.47
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Jupiter Life Line Hospitals Technical
Moving Average
SMA
- 5 Day1463.79
- 10 Day1493.49
- 20 Day1486.49
- 50 Day1462.8
- 100 Day1492.6
- 300 Day1473.04
Jupiter Life Line Hospitals Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Ask Automotive
- 524.1
- 6.25
- 1.21
- 526
- 333.85
- 10332.24
- India Shelter Financ Crpratn
- 878.65
- -2.2
- -0.25
- 939.9
- 603.25
- 9471.83
- Jupiter Life Line Hospitals
- 1459.9
- 19.85
- 1.38
- 1759
- 1177.05
- 9590.45
- Happy Forgings
- 967.25
- -1.25
- -0.13
- 1298.95
- 716.1
- 9138.22
- Akums Drugs And Pharmaceuticals
- 593.35
- 10.1
- 1.73
- 1174.85
- 407.4
- 9338.98
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Ask Automotive
- 39.88
- 9.47
- -
- -
- India Shelter Financ Crpratn
- 24.5
- 3.49
- 13.59
- 29.8
- Jupiter Life Line Hospitals
- 48.39
- 6.9
- 17.18
- 11.07
- Happy Forgings
- 34.19
- 4.94
- -
- -
- Akums Drugs And Pharmaceuticals
- 27.09
- 2.89
- -
- -
Jupiter Life Line Hospitals Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 09-May-25
- Audited Results & Final Dividend
- 07-Feb-25
- Quarterly Results
- 08-Nov-24
- Quarterly Results
- 09-Aug-24
- Quarterly Results
- 10-May-24
- Audited Results & Dividend
- 09-Feb-24
- Quarterly Results
- 10-Nov-23
- Quarterly Results
- 06-Oct-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 29-Oct-24
- 26-Sept-24
- POM
- 09-Aug-24
- 15-Jul-24
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 09-May-25
- 04-Jul-25
- 04-Jul-25
- 1
- 10-May-24
- 02-Aug-24
- 02-Aug-24
- 1


